5 hospitals to hold clinical trials for China’s COVID-19 vaccine

Daphne Galvez 08/31/2020

MANILA, Philippines — The Department of Health has identified five hospitals which will be the site of clinical trials of China-based Sinovac Biotech’s vaccine against the coronavirus disease. These are the Philippine General Hospital, San Lazaro Hospital, Manila…

Moderna COVID-19 vaccine enters final stage trial July 27 — statement

AFP 07/15/2020

WASHINGTON — The US biotech firm Moderna said Tuesday it would enter the final stage of its human trials for its COVID-19 vaccine on July 27, after promising early results were published in a journal. The Phase 3…

IATF OKs Sinovac as PH’s potential collaborator for COVID-19 vaccine dev’t

Krissy Aguilar 06/09/2020

MANILA, Philippines — The Inter-Agency Task Force (IATF) for the Management of Emerging Infectious Diseases has approved the inclusion of Chinese firm Sinovac Biotech Ltd. as potential collaborators of the country on COVID-19 vaccine development and clinical…

Duterte: No COVID-19 vaccine? Opening of classes ‘useless’

Krissy Aguilar 05/26/2020

MANILA, Philippines — For President Rodrigo Duterte, it is “useless” to talk about the opening of classes when there is no vaccine yet against the coronavirus disease (COVID-19). In a televised address on late Monday night, the…

Palace: COVID-19 vaccination plan to prioritize elderly, with comorbidities

Krissy Aguilar - INQUIRER.net 05/20/2020

MANILA, Philippines — Once a vaccine for the coronavirus disease (COVID-19) becomes available, the elderly and those with existing medical conditions will be prioritized, Malacañang said Wednesday. Presidential spokesperson Harry Roque made the assurance as  he disclosed…

Oxford starts human trials for virus vaccine

04/24/2020

LONDON—Oxford University is launching a human trial of a potential coronavirus vaccine, with the daunting aim of making a successful jab available to the public later this year. Of the more than 100 research projects around the…

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.